Brandon Capital: Fund Six Closed At Over A$439 Million
By Amit Chowdhry ● Jul 28, 2025
Brandon Capital, Australasia's leading life sciences venture capital firm, has announced the final close of its sixth fund, the Brandon BioCatalyst Fund Six (BB6), totaling A$439 million. New investors in BB6 include the Western Australia Government and Australia’s National Reconstruction Fund Corporation (NRFC), joining existing backers like Hesta, Host Plus, CSL, and QIC. With this close, Brandon Capital has raised over A$1 billion in total.